Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

High doses of finasteride cause cell growth and tumors in mice.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats male hair loss, improving growth and density.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Finasteride doesn't affect bone density in male rats.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Finasteride exposure harms tadpole reproduction and hormone balance.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that more research is needed to fully understand the causes of PCOS.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.